Services

Vaccinex has developed a powerful and flexible technology platform suitable for selection of fully human antibodies, affinity improvement of antibody candidates and conversion of mouse antibodies to fully human. Vaccinex offers these services on a fee-based schedule as well as in the form of a technology license. Because each application is unique, we invite interested parties to contact us to share ideas concerning how to leverage our technology to advance your scientific interests.

• De novo Selection
• Mouse to Human Conversion
• Affinity Improvement

Feel free to contact us to learn more.